Infection prevention for patients with chemotherapy-induced neutropenia requires a proactive bundle of precautions because their immune system is significantly suppressed, making even small exposures to bacteria, fungi, or other pathogens potentially dangerous. The best approach includes strict hand hygiene by both patients and staff to remove or reduce any pathogens, a private room if possible to limit exposure from other patients, restricted visitors to reduce the introduction of new microbes, and avoiding potential sources of infection such as fresh flowers and raw or undercooked foods as outlined by facility policy. Daily monitoring for infection allows for the earliest detection and treatment of any fever or signs of infection, which is crucial since fever in a neutropenic patient often signifies a serious infection and requires prompt medical attention. This combination directly reduces exposure risk and supports timely intervention, which other options fail to do by omitting key protections or shifting responsibility inappropriately.

Initiating a new chemotherapy order through a central line requires a careful, safety-focused sequence. Verifying line patency ensures the catheter is open and capable of delivering the infusion, preventing drug from leaking into tissue or failing to reach the bloodstream. Checking the exit site for signs of infection reduces the risk of catheter-related bloodstream infection, which is especially important in patients receiving chemotherapy. Confirming the patient’s identity and the order details guards against med errors—giving the wrong drug, dose, or schedule to the wrong person. Flushing with saline per protocol before administration helps clear the line, maintain patency, and prevent drug–line interactions or occlusion. Together, these steps address mechanical, infectious, and medication safety concerns, making the approach the safest. Skipping patency, ignoring order details, or not flushing saline would leave the patient exposed to preventable complications.

Preventing infection during line access relies on strict aseptic technique at every interaction with the line. This means performing hand hygiene before touching the line or its hubs, scrubbing the access port with an appropriate antiseptic, and allowing it to dry so it's truly disinfected before you connect or disconnect anything. Using sterile or properly cleaned equipment and maintaining sterile technique during each access minimizes the chance of introducing microorganisms. Also, removing or replacing lines promptly when they’re no longer needed reduces the duration of exposure and the opportunity for infection to develop. Choosing to rely on gloves alone ignores the need to clean hands first, so it doesn’t adequately prevent contamination. Cleaning the hub only after removal misses the critical window of exposure during use. Wiping with water isn’t a disinfectant and won’t reliably kill microbes, so it’s not effective protection.

When the IV catheter is no longer delivering into a vein, fluid can escape into the surrounding tissue. This leakage into tissue is called infiltration. A common clue for infiltration is the absence of blood return at the IV site, because the catheter tip may have slipped out of the vein or the vein may be collapsed, causing the infused fluid to pool in the surrounding tissue rather than enter the bloodstream. Extravasation, on the other hand, involves leakage of a vesicant chemotherapeutic agent into tissue and carries a high risk of tissue injury. While lack of blood return can occur with extravasation, the key feature is the presence of vesicant-induced damage signs such as severe pain, swelling, redness, or blistering. In the absence of such vesicant-specific signs, the scenario is more consistent with infiltration, making it the best explanation for no blood return in this context.